Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cross screening panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Safety47 Scan (DiscoverX - Eurofins)
Adrenergic alpha2C Eurofins Panlabs panel
Adrenergic alpha2B Eurofins Panlabs panel
Adrenergic alpha2A Eurofins Panlabs panel
ALPHA2A/HU Eurofins SafetyScreen44 (BI)
Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting
Assay data:24 Active, 17 Activity ≤ 1 µM, 40 Tested
Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Assay data:1 Active, 1 Tested
Assay data:63 Active, 20 Activity ≤ 1 µM, 323 Tested
Assay data:195 Active, 66 Activity ≤ 1 µM, 1241 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on